Cramer: We've missed the big move on Sarepta Therapeutics
September 30, 2016 at 19:21 PM EDT
Jim Cramer provides his opinion on various stocks at lightning speed, including Sarepta Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.